Jump Financial LLC Has $2.42 Million Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Jump Financial LLC lifted its stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 400.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 112,421 shares of the health services provider's stock after buying an additional 89,975 shares during the period. Jump Financial LLC owned about 0.07% of Teladoc Health worth $2,423,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the stock. Commonwealth Equity Services LLC grew its holdings in shares of Teladoc Health by 5.7% in the third quarter. Commonwealth Equity Services LLC now owns 80,934 shares of the health services provider's stock valued at $1,505,000 after acquiring an additional 4,344 shares in the last quarter. Raymond James & Associates boosted its holdings in shares of Teladoc Health by 0.9% in the 3rd quarter. Raymond James & Associates now owns 228,238 shares of the health services provider's stock worth $4,243,000 after buying an additional 2,029 shares during the last quarter. Mackenzie Financial Corp grew its position in Teladoc Health by 83.7% during the third quarter. Mackenzie Financial Corp now owns 30,843 shares of the health services provider's stock valued at $570,000 after buying an additional 14,050 shares during the period. Allspring Global Investments Holdings LLC increased its holdings in Teladoc Health by 8.8% during the third quarter. Allspring Global Investments Holdings LLC now owns 50,903 shares of the health services provider's stock worth $946,000 after buying an additional 4,129 shares during the last quarter. Finally, Triumph Capital Management bought a new stake in Teladoc Health in the third quarter worth about $320,000. Institutional investors own 76.82% of the company's stock.

Teladoc Health Trading Up 4.2 %

Shares of Teladoc Health stock traded up $0.50 on Monday, reaching $12.45. The company had a trading volume of 5,276,506 shares, compared to its average volume of 4,883,950. Teladoc Health, Inc. has a 1 year low of $11.88 and a 1 year high of $30.41. The firm has a market cap of $2.11 billion, a price-to-earnings ratio of -8.80 and a beta of 0.97. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.82 and a quick ratio of 3.74. The firm's 50-day moving average price is $14.14 and its two-hundred day moving average price is $17.31.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.47) by ($0.02). The company had revenue of $646.13 million for the quarter, compared to analysts' expectations of $637.31 million. Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.13%. The firm's revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.37) earnings per share. As a group, research analysts predict that Teladoc Health, Inc. will post -1.04 earnings per share for the current fiscal year.

Insider Activity at Teladoc Health

In related news, CTO Nikolaos P. Nanis sold 2,866 shares of the company's stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $41,614.32. Following the transaction, the chief technology officer now directly owns 69,850 shares of the company's stock, valued at approximately $1,014,222. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other Teladoc Health news, insider Daniel Trencher sold 6,780 shares of the company's stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $98,445.60. Following the sale, the insider now directly owns 28,192 shares of the company's stock, valued at $409,347.84. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CTO Nikolaos P. Nanis sold 2,866 shares of the company's stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $41,614.32. Following the completion of the sale, the chief technology officer now owns 69,850 shares in the company, valued at approximately $1,014,222. The disclosure for this sale can be found here. Insiders have sold a total of 138,368 shares of company stock valued at $1,989,227 over the last quarter. 0.95% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms have issued reports on TDOC. Needham & Company LLC restated a "hold" rating on shares of Teladoc Health in a research report on Friday, April 26th. Oppenheimer cut their target price on Teladoc Health from $26.00 to $21.00 and set an "outperform" rating for the company in a research note on Friday, April 26th. Barclays lowered their price target on shares of Teladoc Health from $25.00 to $20.00 and set an "overweight" rating for the company in a report on Friday, April 26th. Leerink Partnrs reaffirmed a "market perform" rating on shares of Teladoc Health in a research note on Monday, February 26th. Finally, Wells Fargo & Company decreased their price target on shares of Teladoc Health from $17.00 to $15.00 and set an "equal weight" rating for the company in a research note on Monday, April 29th. Twelve research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $18.73.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.